The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Advanced drug delivery to the lymphatic system: lipid-based nanoformulations
Open accessAbstract
The delivery of drugs and bioactive compounds via the lymphatic system is complex and dependent on the physiological uniqueness of the system. The lymphatic route plays an important role in transporting extracellular fluid to maintain homeostasis and in transferring immune cells to injury sites, and is able to avoid first-pass metabolism, thus acting as a bypass route for compounds with lower bioavailability, ie, those undergoing more hepatic metabolism. The lymphatic route also provides an option for the delivery of therapeutic molecules, such as drugs to treat cancer and human immunodeficiency virus, which can travel through the lymphatic system. Lymphatic imaging is useful in evaluating disease states and treatment plans for progressive diseases of the lymph system. Novel lipid-based nanoformulations, such as solid lipid nanoparticles and nanostructured lipid carriers, have unique characteristics that make them promising candidates for lymphatic delivery. These formulations are superior to colloidal carrier systems because they have controlled release properties and provide better chemical stability for drug molecules. However, multiple factors regulate the lymphatic delivery of drugs. Prior to lymphatic uptake, lipid-based nanoformulations are required to undergo interstitial hindrance that modulates drug delivery. Therefore, uptake and distribution of lipid-based nanoformulations by the lymphatic system depends on factors such as particle size, surface charge, molecular weight, and hydrophobicity. Types of lipid and concentration of the emulsifier are also important factors affecting drug delivery via the lymphatic system. All of these factors can cause changes in intermolecular interactions between the lipid nanoparticle matrix and the incorporated drug, which in turn affects uptake of drug into the lymphatic system. Two lipid-based nanoformulations, ie, solid lipid nanoparticles and nanostructured lipid carriers, have been administered via multiple routes (subcutaneous, pulmonary, and intestinal) for targeting of the lymphatic system. This paper provides a detailed review of novel lipid-based nanoformulations and their lymphatic delivery via different routes, as well as the in vivo and in vitro models used to study drug transport in the lymphatic system. Physicochemical properties that influence lymphatic delivery as well as the advantages of lipid-based nanoformulations for lymphatic delivery are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc865 · Cited by 3,911
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00118-7 · Cited by 2,113
O’Brien, M. E. R., Wigler, N., Inbar, M., Rosso, R., Grischke, E., Santoro, A., Catane, R., Kieback, D. G., Tomczak, P., Ackland, S. P., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh097 · Cited by 1,738
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
Clogston, J. D., & Patri, A. K. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-60327-198-1_6 · Cited by 1,324
Dissecting the metastatic cascade
Pantel, K., & Brakenhoff, R. H. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1370 · Cited by 1,281
Nanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,226
Barriers to Drug Delivery in Solid Tumors
Jain, R. K. (1994) · Scientific American · doi:10.1038/scientificamerican0794-58 · Cited by 1,069
Iqbal, J., & Hussain, M. M. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90899.2008 · Cited by 811
Eldridge, J. H., Hammond, C. J., Meulbroek, J. A., Staas, J. K., Gilley, R. M., & Tice, T. R. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90133-e · Cited by 689
Microsatellite alterations in plasma DNA of small cell lung cancer patients
Qi Chen, X., Stroun, M., Magnenat, J.-L., Nicod, L. P., Kurt, A.-M., Lyautey, J., Lederrey, C., & Anker, P. (1996) · Nature Medicine · doi:10.1038/nm0996-1033 · Cited by 647
Kommuru, T. R., Gurley, B., Khan, M. A., & Reddy, I. K. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00614-1 · Cited by 624
Jenning, V., Thünemann, A. F., & Gohla, S. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00378-1 · Cited by 593
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles☆
WONG, H., BENDAYAN, R., RAUTH, A., LI, Y., & WU, X. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.008 · Cited by 578
Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria
Wells, J. M., & Mercenier, A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1840 · Cited by 537
Lipid-Based Delivery Systems and Intestinal Lymphatic Drug Transport: A Mechanistic Update
Trevaskis, N. L., Charman, W. N., & Porter, C. J. H. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.007 · Cited by 442
Lymphatic uptake and biodistribution of liposomes after subcutaneous injection.
Oussoren, C., Zuidema, J., Crommelin, D. J. A., & Storm, G. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00122-3 · Cited by 380
Lipid-based formulations for intestinal lymphatic delivery
O’Driscoll, C. M. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00051-9 · Cited by 372
Liposomes to target the lymphatics by subcutaneous administration
Oussoren, C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00154-5 · Cited by 342
Dahan, A., & Hoffman, A. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.021 · Cited by 341
Intestinal lymphatic drug transport: an update
Porter, C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00151-x · Cited by 337
Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral Administration
Yang, S., Zhu, J., Lu, Y., Liang, B., & Yang, C. (1999) · Pharmaceutical Research · doi:10.1023/a:1018888927852 · Cited by 324
Zhuang, C.-Y., Li, N., Wang, M., Zhang, X.-N., Pan, W.-S., Peng, J.-J., Pan, Y.-S., & Tang, X. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.05.005 · Cited by 318
Hauss, D. J., Fogal, S. E., Ficorilli, J. V., Price, C. A., Roy, T., Jayaraj, A. A., & Keirns, J. J. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970300n · Cited by 316
Serum opsonins and liposomes: their interaction and opsonophagocytosis.
Patel, H. M. (1992) · PubMed · Cited by 297
O'Driscoll, C. M., & Griffin, B. T. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.012 · Cited by 296
Paliwal, R., Rai, S., Vaidya, B., Khatri, K., Goyal, A. K., Mishra, N., Mehta, A., & Vyas, S. P. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.08.003 · Cited by 288
MEASUREMENT OF TOTAL LUNG DEPOSITION OF INHALED ULTRAFINE PARTICLES IN HEALTHY MEN AND WOMEN
Peter A. Jaques, C. S. K. (2000) · Inhalation Toxicology · doi:10.1080/08958370050085156 · Cited by 287
Intestinal lymphatic transport for drug delivery
Yáñez, J. A., Wang, S. W. J., Knemeyer, I. W., Wirth, M. A., & Alton, K. B. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.019 · Cited by 278
Transmural Flow Modulates Cell and Fluid Transport Functions of Lymphatic Endothelium
Miteva, D. O., Rutkowski, J. M., Dixon, J. B., Kilarski, W., Shields, J. D., & Swartz, M. A. (2010) · Circulation Research · doi:10.1161/circresaha.109.207274 · Cited by 255
Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles
Cai, S., Yang, Q., Bagby, T. R., & Forrest, M. L. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.017 · Cited by 252
Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide
Jacobs, C., Kayser, O., & Müller, R. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00412-3 · Cited by 232
Estimating the Maximal Potential for Intestinal Lymphatic Transport of Lipophilic Drug Molecules
Charman, W. N. A., & Stella, V. J. (1986) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(86)90027-x · Cited by 217
Lymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid Nanoparticles
Videira, M. A., Botelho, M. F., Santos, A. C., Gouveia, L. F., Pedroso de Lima, J. J., & Almeida, A. J. (2002) · Journal of Drug Targeting · doi:10.1080/1061186021000054933 · Cited by 213
Harivardhan Reddy, L., Sharma, R. K., Chuttani, K., Mishra, A. K., & Murthy, R. S. R. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.028 · Cited by 212
The Lymph Node as a Bridgehead in the Metastatic Dissemination of Tumors
Sleeman, J. P. (2000) · Recent Results in Cancer Research · doi:10.1007/978-3-642-57151-0_6 · Cited by 207
Dahlb�ck, B., Hermansson, M., Kjelleberg, S., & Norkrans, B. (1981) · Archives of Microbiology · doi:10.1007/bf00422527 · Cited by 185
Hawley, A. E., Davis, S. S., & Illum, L. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00045-9 · Cited by 183
Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery
Rao, D. A., Forrest, M. L., Alani, A. W. G., Kwon, G. S., & Robinson, J. R. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21970 · Cited by 182
Oral particulate delivery: status and future trends
Chen, H. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00047-7 · Cited by 181
Dahan, A., & Hoffman, A. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.12.006 · Cited by 179
Studies on oral absorption of stearic acid SLN by a novel fluorometric method
Yuan, H., Chen, J., Du, Y.-Z., Hu, F.-Q., Zeng, S., & Zhao, H.-L. (2007) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2007.03.002 · Cited by 176
Preparation and Bioavailability Assessment of SMEDDS Containing Valsartan
Dixit, A. R., Rajput, S. J., & Patel, S. G. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9385-0 · Cited by 168
Muller, R. H., Radtke, M., & Wissing, S. A. (2003) · ChemInform · doi:10.1002/chin.200335261 · Cited by 164
LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors
Luo, G., Yu, X., Jin, C., Yang, F., Fu, D., Long, J., Xu, J., Zhan, C., & Lu, W. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.10.014 · Cited by 161
Khoo, S., Shackleford, D. M., Porter, C. J. H., Edwards, G. A., & Charman, W. N. (2003) · Pharmaceutical Research · doi:10.1023/a:1025718513246 · Cited by 150
Solid Lipid Nanoparticles in Lymph and Plasma After Duodenal Administration to Rats
Bargoni, A., Cavalli, R., Caputo, O., Fundaro', A., Gasco, M. R., & Zara, G. P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011975120776 · Cited by 148
Frenkel, V., Etherington, A., Greene, M., Quijano, J., Xie, J., Hunter, F., Dromi, S. A., & Li, K. C. (2006) · Academic Radiology · doi:10.1016/j.acra.2005.08.024 · Cited by 148
Chalikwar, S. S., Belgamwar, V. S., Talele, V. R., Surana, S. J., & Patil, M. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.04.027 · Cited by 146
Saupe, A., Wissing, S. A., Lenk, A., Schmidt, C., & Müller, R. H. (2005) · PubMed · Cited by 144
Zara, G. P., Bargoni, A., Cavalli, R., Fundaro', A., Vighetto, D., & Gasco, M. R. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10129 · Cited by 143
Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells
Choi, S. H. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.07.011 · Cited by 136
Moghimi, S. M. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00099-4 · Cited by 135
Uptake of drugs into the intestinal lymphatics after oral administration
Porter, C. J. H., & Charman, W. N. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00492-9 · Cited by 135
Targeting the lymphatics using dendritic polymers (dendrimers)
Kaminskas, L. M., & Porter, C. J. H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.016 · Cited by 133
Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin
Cavalli, R., Bargoni, A., Podio, V., Muntoni, E., Zara, G. P., & Gasco, M. R. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10368 · Cited by 133
Gershkovich, P., & Hoffman, A. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.07.011 · Cited by 132
Intralymphatic Chemotherapy Using a Hyaluronan–Cisplatin Conjugate
Cai, S., Xie, Y., Bagby, T. R., Cohen, M. S., & Forrest, M. L. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2008.02.048 · Cited by 132
Preclinical evaluation of a pulmonary delivered paclitaxel-loaded lipid nanocarrier antitumor effect
Videira, M., Almeida, A. J., & Fabra, À. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.12.007 · Cited by 130
Baboota, S., Shah, F. M., Javed, A., & Alka, A. (2009) · Journal of drug targeting · doi:10.1080/10611860902718672 · Cited by 128
Lymphatic targeting of zidovudine using surface-engineered liposomes
Kaur, C. D., Nahar, M., & Jain, N. K. (2008) · Journal of drug targeting · doi:10.1080/10611860802475688 · Cited by 127
Sun, M., Zhai, X., Xue, K., Hu, L., Yang, X., Gao, L., & Si, L. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.04.011 · Cited by 124
Thakkar, H. P., Nangesh, J., Parmar, M. P., & Patel, D. (2011) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.84463 · Cited by 122
Cisplatin‐incorporated hyaluronic acid nanoparticles based on ion‐complex formation
Jeong, Y., Kim, S., Jin, S., Ryu, H., Jin, Y., Jung, T., Kim, I., & Jung, S. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21103 · Cited by 119
Singh, B., Khurana, L. K., Bandyopadhyay, S., Kapil, R., & Katare, O. P. (2011) · Drug Delivery · doi:10.3109/10717544.2011.604686 · Cited by 116
Animal models for the study of intestinal lymphatic drug transport
Edwards, G. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00148-x · Cited by 112
Khoo, S., Edwards, G. A., Porter, C. J. H., & Charman, W. N. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1110 · Cited by 111
Kinetics of particle uptake in the domes of Peyer’s patches
Beier, R., & Gebert, A. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.275.1.g130 · Cited by 110
Drug Delivery to the Lymphatic System
Porter, C. J. H. (1997) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v14.i4.10 · Cited by 100
The role of the lymphatic system in subcutaneous absorption of macromolecules in the rat model
Kagan, L., Gershkovich, P., Mendelman, A., Amsili, S., Ezov, N., & Hoffman, A. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.04.002 · Cited by 95
Enhanced lymphatic delivery of mitomycin C conjugated with dextran.
Takakura, Y., Matsumoto, S., Hashida, M., & Sezaki, H. (1984) · PubMed · Cited by 93
Ling, S. S. N., Magosso, E., Khan, N. A. K., Yuen, K. H., & Barker, S. A. (2006) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040500519102 · Cited by 93
Liu, J., Meisner, D., Kwong, E. C., Wu, X. Y., & Johnston, M. R. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.03.022 · Cited by 91
Patel, H. M., Boodle Katherine, M., & Vaughan‐Jones, R. D. (1984) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(84)90214-9 · Cited by 88
Liggins, R., D’Amours, S. K., Demetrick, J. S., Machan, L. S., & Burt, H. M. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00080-6 · Cited by 82
Lymphatic Targeting of Polymeric Nanoparticles After Intraperitoneal Administration in Rats
Maincent, P., Thouvénot, P., Amicabile, C., Hoffman, M., Kreuter, J., Couvreur, P., & Devissaguet, J. P. (1992) · Pharmaceutical Research · doi:10.1023/a:1015895804597 · Cited by 76
Li, X., Yuan, Q., Huang, Y., Zhou, Y., & Liu, Y. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9432-x · Cited by 76
Seeballuck, F., Lawless, E., Ashford, M. B., & O’Driscoll, C. M. (2004) · Pharmaceutical Research · doi:10.1007/s11095-004-7684-4 · Cited by 75
Seeballuck, F., Ashford, M. B., & O’Driscoll, C. M. (2003) · Pharmaceutical Research · doi:10.1023/a:1024422625596 · Cited by 73
Advances in lymphatic imaging and drug delivery
Nune, S. K., Gunda, P., Majeti, B. K., Thallapally, P. K., & Forrest, M. L. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.020 · Cited by 73
Boyd, M. C., Risovic, V., Jull, P., Choo, E., & Wasan, K. M. (2004) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2003.11.004 · Cited by 70
Kojima, N., Biao, L., Nakayama, T., Ishii, M., Ikehara, Y., & Tsujimura, K. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.023 · Cited by 69
Lipid nanoparticles: recent advances☆
MULLER, R. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.002 · Cited by 68
Small-cell lung cancer: treatment progress and prospects.
Clark, R. E., & Ihde, D. C. (1998) · PubMed · Cited by 65
Lu, H., Li, B., Kang, Y., Jiang, W., Huang, Q., Chen, Q., Li, L., & Xu, C. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0256-z · Cited by 63
Lawson, K. A., Anderson, K., Snyder, R. M., Simmons-Menchaca, M., Atkinson, J., Sun, L., Bandyopadhyay, A. M., Knight, V., Gilbert, B. E., Sanders, B. G., et al. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0817-y · Cited by 62
Targeting colloidal particulates to thoracic lymph nodes
Liu, J., Wong, H. L., Moselhy, J., Bowen, B. M., Wu, X. Y., & Johnston, M. R. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2005.11.006 · Cited by 57
Cavalli, R., Zara, G. P., Caputo, O., et al. (2000) · Pharmacological Research · doi:10.1006/phrs.2000.0737 · Cited by 57
Myers, R. A., & Stella, V. J. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90261-y · Cited by 53
Preparation of nobiletin in self-microemulsifying systems and its intestinal permeability in rats
Yao, J., Lu, Y., & Zhou, J. (2008) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3ms3m · Cited by 51
Role of the lymphatics in cancer metastasis and chemotherapy applications
McAllaster, J., & Cohen, M. S. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.014 · Cited by 51
Latimer, P., Simmons-Menchaca, M., Snyder, R. M., Yu, W., Gilbert, B. E., Sanders, B. G., & Kline, K. A. (2009) · Experimental Biology and Medicine · doi:10.3181/0901-rm-8 · Cited by 47
Wu, H., Zhou, A., Lu, C., & Wang, L. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.12.010 · Cited by 44
Successful in silico predicting of intestinal lymphatic transfer
Holm, R., & Hoest, J. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.12.017 · Cited by 43
McIntire, G. L., Bacon, E. R., Toner, J. L., Cornacoff, J. B., Losco, P. E., Illig, K. J., Nikula, K. J., Muggenburg, B. A., & Ketai, L. H. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980060r · Cited by 42
Lespine, A., Chanoit, G. P. A., Bousquet‐mélou, A., Lallemand, E. A., Bassissi, F., Alvinerie, M., & Toutain, P. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.08.003 · Cited by 35
White, D. G., Story, M. J., & Barnwell, S. G. (1991) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(91)90221-9 · Cited by 35
Pathology of carcinoma of lung
Haque, A. K. (1991) · Journal of Thoracic Imaging · doi:10.1097/00005382-199112000-00004 · Cited by 35
Pharmacokinetics of Recombinant Human Leukemia Inhibitory Factor in Sheep
Segrave, A. M., Mager, D. E., Charman, S. A., Edwards, G. A., & Porter, C. J. H. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.063289 · Cited by 34
Bocci, V. A., Muscettola, M., Grasso, G., Magyar, Z., Naldini, A., & Szabo, G. B. (1986) · Cellular and Molecular Life Sciences · doi:10.1007/bf02118644 · Cited by 32
Lymph Flow Pattern in the Intact Thoracic Duct in Sheep
Onizuka, M., Flatebø, T., & Nicolaysen, G. (1997) · The Journal of Physiology · doi:10.1111/j.1469-7793.1997.223bi.x · Cited by 29
Moghimi, S. M., & Moghimi, M. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.08.033 · Cited by 27
Novel approaches to the treatment of small-cell lung cancer
Zangemeister‐Wittke, U., & Stahel, R. A. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050398 · Cited by 26
Supramicron-sized particle clearance from alveoli: route and kinetics
Langenback, E. G., Bergofsky, E. H., Halpern, J. G., & Foster, W. M. (1990) · Journal of Applied Physiology · doi:10.1152/jappl.1990.69.4.1302 · Cited by 25
The relationship between tumors and the lymphatics: what more is there to know?
Sleeman, J. P. (2006) · PubMed · Cited by 23
Walker, J. E., Odden, A. R., Jeyaseelan, S., Zhang, P., Bagby, G. J., Nelson, S., & Happel, K. I. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00844.x · Cited by 22
Potential for lymphatic targeting of peptides
Muranishi, S., Fujita, T., Murakami, M., & Yamamoto, A. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01588-x · Cited by 22
Lymphangiogenesis is pivotal to the trials of a successful cancer metastasis
McCarter, M. D., Clarke, J. H., & Harken, A. H. (2004) · Surgery · doi:10.1016/s0039-6060(03)00342-8 · Cited by 19
Lymphatic chemotherapy induces apoptosis in lymph node metastases in a rabbit breast carcinoma model
Ling, R., Li, Y., Yao, Q., Chen, T., Zhu, D., Jun, Y., & Chen, J. (2005) · Journal of drug targeting · doi:10.1080/10611860400027725 · Cited by 18
Karpf, D. M., Holm, R., Garafalo, C., Levy, E. H., Jacobsen, J. B., & Müllertz, A. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20431 · Cited by 17
Targeting colloidal particulates to thoracic lymph nodes. Lung Cancer
Liu, J., Wong, H. L., Moselhy, J., et al. (2006) · Cited by 7
Cited by
Nanoemulsion: Concepts, development and applications in drug delivery
Singh, Y., Meher, J. G., Raval, K., Khan, F. A., Chaurasia, M., Jain, N. K., & Chourasia, M. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.008 · Cited by 1,358
Nanoparticles for oral delivery: Design, evaluation and state-of-the-art
Date, A. A., Hanes, J., & Ensign, L. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.016 · Cited by 539
Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers
Haddadzadegan, S., Dorkoosh, F., & Bernkop-Schnürch, A. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114097 · Cited by 424
Nanoemulsion: An Emerging Novel Technology for Improving the Bioavailability of Drugs
Preeti, Sambhakar, S., Malik, R., Bhatia, S., Al Harrasi, A., Rani, C., Saharan, R., Kumar, S., Geeta, & Sehrawat, R. (2023) · Scientifica · doi:10.1155/2023/6640103 · Cited by 331
Lin, C.-H., Chen, C.-H., Lin, Z.-C., & Fang, J.-Y. (2017) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2017.02.001 · Cited by 298
Metadata
- Authors
- Darwis, Y., Ali Khan, A., Mudassir, J., & Mohtar, N.
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2013-07
- Volume
- 8
- Pages
- 2733
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W2022258204
- Cited by
- 333
- References
- 114
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.